The activation of AMPK triggers its downstream target, the tuberous sclerosis complex 2 (TSC2), which inhibits the mTOR signaling pathway, and hampers the activation of ribosomal protein S6 kinase beta-1 (p70S6K/pS6), necessary for cancer cell growth [9]. Here, RPS6KB1 is linked to cancer.